Cargando…

Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Identification of early-stage tumor and monitoring therapeutic efficacy and recurrence or metastasis of colorectal cancer (CRC) are urgently warranted for improving the outcome of CRC patients and reducing the disease-related mortality. In this study, we evaluated the diagnostic value of cell-free c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Bo, Yan, Peng, Zhang, Shan, Lu, Yan, Pan, Li, Tang, Wenqiang, Chen, Shen, Chen, Shuangfeng, Zhang, Anqi, Liu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937566/ https://www.ncbi.nlm.nih.gov/pubmed/29849824 http://dx.doi.org/10.1155/2018/6437104

Ejemplares similares

Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022)

SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma
por: Li, Baoliang, et al.
Publicado: (2020)

The role of (m)SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
por: Sun, Jie, et al.
Publicado: (2019)

Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
por: Yuan, Zhen, et al.
Publicado: (2022)

Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection
por: Wang, Yu, et al.
Publicado: (2018)

Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients
por: Jiang, Huiqin, et al.
Publicado: (2021)

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
por: Church, Timothy Robert, et al.
Publicado: (2014)

Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis
por: Nian, Jiayun, et al.
Publicado: (2017)

Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
por: Krausewitz, Philipp, et al.
Publicado: (2022)

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas
por: Semaan, Alexander, et al.
Publicado: (2016)

Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis
por: Hu, Jincui, et al.
Publicado: (2019)

Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
por: Liu, Yi, et al.
Publicado: (2020)

Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
por: Bergheim, Julia, et al.
Publicado: (2018)

Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma
por: Huang, Fei, et al.
Publicado: (2022)

SNHG3 Affects Gastric Cancer Development by Regulating SEPT9 Methylation
por: Li, Wei, et al.
Publicado: (2022)

Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report
por: Powrózek, Tomasz, et al.
Publicado: (2014)

Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer
por: Loomans-Kropp, Holli A., et al.
Publicado: (2022)

Plasma circulating cell‐free MYCN gene: A noninvasive and prominent recurrence monitoring indicator of neuroblastoma
por: Liang, Ying, et al.
Publicado: (2022)

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
por: Zhao, Guodong, et al.
Publicado: (2020)

Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population
por: Lima, Adhara Brandão, et al.
Publicado: (2023)

Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
por: Oussalah, Abderrahim, et al.
Publicado: (2018)

Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population
por: Zheng, Kepu, et al.
Publicado: (2023)

Circulating methylated Septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer
por: Cao, Chang-Qi, et al.
Publicado: (2020)

Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy
por: Hariharan, Rohit, et al.
Publicado: (2020)

Alternative Splicing of sept9a and sept9b in Zebrafish Produces Multiple mRNA Transcripts Expressed Throughout Development
por: Landsverk, Megan L., et al.
Publicado: (2010)

Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions
por: Tänzer, Marc, et al.
Publicado: (2010)

Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance
por: Jiao, Xinlin, et al.
Publicado: (2019)

Physicists to host forum on particle accelerator Sept. 9
Publicado: (2008)

The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation
por: Zhang, Nianzhu, et al.
Publicado: (2016)

Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis
por: Cheuk, Isabella Wai Yin, et al.
Publicado: (2017)

Identification of a 5-Hydroxymethylation Signature in Circulating Cell-Free DNA for the Noninvasive Detection of Colorectal Cancer
por: Liu, Hongwei, et al.
Publicado: (2022)

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
por: Lin, Wu-Hao, et al.
Publicado: (2021)

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites
por: Jung, Maria, et al.
Publicado: (2016)

Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma
por: Kotoh, Yurika, et al.
Publicado: (2020)

DNA hypomethylation of CBS promoter induced by folate deficiency is a potential noninvasive circulating biomarker for colorectal adenocarcinomas
por: Xue, Geng, et al.
Publicado: (2017)

Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection
por: Xie, Li, et al.
Publicado: (2018)

Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers
por: Song, Lele, et al.
Publicado: (2020)

Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer
por: Lu, Pingxia, et al.
Publicado: (2022)

Expression of sept3, sept5a and sept5b in the Developing and Adult Nervous System of the Zebrafish (Danio rerio)
por: Helmprobst, Frederik, et al.
Publicado: (2017)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8nar58fkc183o7nhqtf8d4ugji